Daniel M Marko

15PUBLICATIONS
44CO-AUTHORS
Toxicology (incl. clinical toxicology)Innate immunityMedical bacteriologyPsychophysiologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 19, 2026
Statins promote muscle metabolic danger and NLRP3-mediated myopathy via lower protein-prenylation and YAP.

|Mar 09, 2026
Immunometabolism of IRF4 in adipose, muscle, and immune cells influences obesity and MASLD.

Daniel M Marko, Jonathan D Schertzer

|Jan 19, 2026
Postbiotic gut bacteria site-specific immunomodulators improve liver steatosis, inflammation, and fibrosis in obese mice with MASLD.

Rodrigo Rodrigues E-Lacerda, Nicole G Barra, Meghan O Conn

|Apr 15, 2025
GDF15 links adipose tissue lipolysis with anxiety.

Logan K Townsend, Dongdong Wang, Carly M Knuth

|Feb 10, 2025
Microbiota protect against frailty and loss of skeletal muscle, and maintain inflammatory tone during aging in mice.

Meghan O Conn, Erica N DeJong, Daniel M Marko

|Jan 24, 2025
Brain-derived neurotrophic factor drives muscle adaptation similar to aerobic training in mice.

Alexander D Brown, Alexander D Marko, Daniel M Marko

Pageof 3

Frequent Collaborators

7 joint publications

Rebecca E K MacPherson

7 joint publications

Jonathan D Schertzer

4 joint publications

Michael S Finch

3 joint publications

Meghan O Conn